CD44: a cancer stem cell marker and therapeutic target in leukemia treatment

被引:10
|
作者
Wu, Shuang [1 ,2 ]
Tan, Yicheng [1 ,2 ,3 ]
Li, Fanfan [2 ,3 ,4 ]
Han, Yixiang [2 ,3 ,5 ]
Zhang, Shenghui [1 ,2 ,3 ,4 ]
Lin, Xiaofei [4 ]
机构
[1] Wenzhou Med Univ, Lab Anim Ctr, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Inst Hematol, Wenzhou, Zhejiang, Peoples R China
[3] Wenzhou Key Lab Hematol, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Dept Hematol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[5] Wenzhou Med Univ, Cent Lab, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金
中国国家自然科学基金;
关键词
CD44; leukemia; adhesion; migration; homing; differentiation; biomarkers; clinical application; ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; HYALURONAN-CD44; INTERACTION; ADHESION MOLECULES; SOLUBLE CD44; BONE-MARROW; POOR-PROGNOSIS; ERM PROTEINS; SERUM CD44; EXPRESSION;
D O I
10.3389/fimmu.2024.1354992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD44 is a ubiquitous leukocyte adhesion molecule involved in cell-cell interaction, cell adhesion, migration, homing and differentiation. CD44 can mediate the interaction between leukemic stem cells and the surrounding extracellular matrix, thereby inducing a cascade of signaling pathways to regulate their various behaviors. In this review, we focus on the impact of CD44s/CD44v as biomarkers in leukemia development and discuss the current research and prospects for CD44-related interventions in clinical application.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Metformin treatment decreases the expression of cancer stem cell marker CD44 and stemness related gene expression in primary oral cancer cells
    Patil, Shankargouda
    ARCHIVES OF ORAL BIOLOGY, 2020, 113
  • [32] EXPRESSION OF CD44 (CANCER STEM CELL MARKER) AS RECURRENCE PROGNOSTIC FACTOR IN STAGE III EPITHELIAL OVARIAN CANCER
    Mulawardhana, P.
    Hartono, P.
    Yuliati, I.
    Sudiana, K.
    Pascawardhana, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1985 - 1985
  • [33] Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer
    Watanabe, Toru
    Okumura, Tomoyuki
    Hirano, Katsuhisa
    Yamaguchi, Tetsuji
    Sekine, Shinichi
    Nagata, Takuya
    Tsukada, Kazuhiro
    ONCOLOGY LETTERS, 2017, 13 (01) : 281 - 288
  • [34] EXPRESSION OF STEM CELL MARKER CD44 IN PROSTATE CANCER BIOPSIES PREDICTS CANCER GRADE IN RADICAL PROSTATECTOMY SPECIMENS
    Korski, Konstanty
    Malicka-Durczak, Anna
    Breborowicz, Jan
    POLISH JOURNAL OF PATHOLOGY, 2014, 65 (04) : 291 - 295
  • [35] Constitutive expression of the potential stem cell marker CD44 in permanent HNSCC cell lines
    Pries, R.
    Wittkopf, N.
    Hasselbacher, K.
    Wollenberg, B.
    HNO, 2008, 56 (04) : 461 - 465
  • [36] Whether CD44 is an applicable marker for glioma stem cells
    Wang, Hsiao-Han
    Liao, Chen-Chieh
    Chow, Nan-Haw
    Huang, Lynn Ling-Huei
    Chuang, Jih-Ing
    Wei, Kuo-Chen
    Shin, Jyh-Wei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (11): : 4785 - 4806
  • [37] CD44: A New Prognostic Marker in Colorectal Cancer?
    Ziranu, Pina
    Pretta, Andrea
    Aimola, Valentina
    Cau, Flaviana
    Mariani, Stefano
    D'Agata, Alessandra Pia
    Codipietro, Claudia
    Rizzo, Daiana
    Dell'Utri, Veronica
    Sanna, Giorgia
    Moledda, Giusy
    Cadoni, Andrea
    Lai, Eleonora
    Puzzoni, Marco
    Pusceddu, Valeria
    Castagnola, Massimo
    Scartozzi, Mario
    Faa, Gavino
    CANCERS, 2024, 16 (08)
  • [38] Curcumin Induces Apoptosis of Colorectal Cancer Stem Cells by Coupling with CD44 Marker
    Huang, Yu-Ting
    Lin, Yu-Wei
    Chiu, Han-Mo
    Chiang, Been-Huang
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2016, 64 (11) : 2247 - 2253
  • [39] Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
    Wang, Chunxia
    Xie, Jingping
    Gu, Jiasong
    Manning, H. Charles
    Gore, John C.
    Guo, Ning
    ONCOLOGY REPORTS, 2012, 28 (04) : 1301 - 1308
  • [40] Modulation of breast cancer stem cell marker CD44 by all-trans-retinoic acid (ATRA)
    Kitadai, Rui
    Bednarczyk, Robert
    Tuli, Neha
    Hanly, Elyse
    Benrahoma, Ghada
    Suriano, Robert
    Mittelman, Abraham
    Tiwari, Raj K.
    CANCER RESEARCH, 2014, 74 (19)